Inactive Instrument

Transcripts Atrinsic, Inc. Other OTC

Stocks

End-of-day quote Other OTC
- ^USD	-

08-20	Protagenic Therapeutics Receives Fda Pre-Ind Feedback Supporting New Ind for Pt00114 in Generalized Anxiety Disorder	CI
08-19	Protagenic Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

21-09-08	Protagenic Therapeutics, Inc. - Special Call
21-07-13	Protagenic Therapeutics, Inc. - Special Call

No results match your criteria